Ghiragosian Claudiu, Harpa Marius, Stoica Alexandra, Sânziana Flămînd Oltean, Bălău Radu, Hussein Hussam Al, Elena Ghiragosian-Rusu Simina, Neagoe Radu Mircea, Suciu Horațiu
Department of Surgery IV, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
Department of Anatomy-Embriolog M1, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
J Cardiovasc Dev Dis. 2022 Jun 2;9(6):178. doi: 10.3390/jcdd9060178.
The race for an ideal cardioplegic solution has remained enthusiastic since the beginning of the modern cardiac surgery era. The Bretschneider solution, belonging to the "intracellular cardioplegic" group, is safe and practical in myocardial protection during ischemic time. Over time, some particular concerns have arisen regarding the effects on cardiac metabolism and postoperative myocardial functioning. This paper reviews the most important standpoints in terms of theoretical and practical analyses.
自现代心脏外科手术时代开始以来，对于理想心脏停搏液的探索一直热情高涨。布雷施奈德溶液属于“细胞内心脏停搏液”类别，在缺血期间的心肌保护方面安全且实用。随着时间的推移，人们对其对心脏代谢和术后心肌功能的影响产生了一些特殊担忧。本文从理论和实践分析的角度回顾了最重要的观点。
